warech

Precisely. Within ISO 9001/13485 certified companies, an individual (usually head of quality/regulatory) is designated the Quality System Management Representative. This individual is explicitly powered by the chief executive with the "responsibility and authority to ensure proper functioning of the quality system" and expected to 'pull the plug' when quality/compliance is at risk.

Not math but could be interesting anyway: Genomics, specifically quality engineering. When hiring for my team we ask candidates to generally describe 1) DNA translation and 2) statistics for experimental design (AQL, RQL, etc).

As personalized medicine becomes more mainstream, it will be important to use accurate terminology in general overviews like OP's website. For example, 23andme does not provide DNA sequencing. Instead, they evaluate samples against a comprehensive panel of small nucleotide polymorphisms. This "fingerprinting" is informative and actionable, but not technically sequencing. In the same way, I doubt whether Genetik Ink will actually "take your DNA, sequence it, and turn it into an artistic representation" for <$500 (full genome sequencing is still $5000+, though dropping quickly in cost).

That is not the definition of abuse. Per DSM-IV criteria for substance abuse addiciton:

"One of the following must be present within a 12 month period: (1) recurrent use resulting in a failure to fulfill major obligations at work, school, or home; (2) recurrent use in situations which are physically hazardous (e.g., driving while intoxicated); (3) legal problems resulting from recurrent use; or (4) continued use despite significant social or interpersonal problems caused by the substance use."

Implementing a rotational leadership program in the mold of GE, Nielsen, Abbot Labs, et al was definitely a great accomplishment for Mayer. I would hesitate, however, to call this a "secret weapon." She would be wise to implement a similar program at Yahoo, but implying that significant APMs would follow her from Google out of 'den mother' loyalty is ridiculous.

This tagline is misleading. A single paragraph discusses "How Yahoo kept it all under wraps" while the rest of the article is an also-ran discussion about Mayer's potential success/failure at Yahoo.

"Xiaomi appears to have hit a sweet spot in the market, selling high-spec devices that compete with the iPhone on quality, but undercut it substantially in price" This strategy follows Christensen's disruptive innovation to the letter. Interesting to see Apple on the brink of disruption in a consumer category it principally defined.

FDA requirements for electronic data transmission (21 CFR Part 11) are a hassle to implement even for devices starting from a blank slate. That being said the sooner NTP standards are universally required, the better. As the article mentions it will be very resource-intensive to retrofit devices for this standardization - an EMR consultant's dream project.

I'm surprised the DoD is spending as little as $250MM on this type of Big Data/AI research. Most of the technology outlined in Lemnois' memo is interesting and exciting, rather than intimidating and indicative of "Terminator development." I'm particularly excited about "reasoning and inference engines that can learn from experience with little training and within mission timeframes" and advances in "human-machine interfaces to enable seamless collaboration for operations and for training." Maybe a little less hyperbole in the post title next time?